Latest stories on TNXP
Tonix Advances TNX-102 SL Into Phase 2 Depression Trial, Drawing Investor Focus
TipRanks58 · neutralproduct/pr
Tonix Pharma Highlights Positive Phase 1 TNX-1500 Results
TipRanks67 · bullishproduct/pr
TNXP news roundup. 1 story in the past week, 5 over 30 days. Average 30-day sentiment is 58.8/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.